Stockreport

Therapix Biosciences Announces Completion of Enrollment of Phase IIa Study at Yale University for Tourette Syndrome Program

THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE  (TRPX) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/trpx